Long-Term Liabilities to Equity: Align Corp (ALGN)

Official company branding of Align Corp (ALGN)

Align Technology, Inc. (ALGN) business is vulnerable to declining consumer purchasing power and pressure from budget alternatives due to patent expirations. However, the company relies on a global 3D printing and air delivery network, which ensures high profitability. This price chart of the asset's market trend on GURU.Markets, where the indicator is 0.02, confirms the brand's leadership in digital dentistry, successfully resisting the onslaught of low-cost services.

Align Technology Inc (ALGN): Long-Term Debt to Capital from 07/04/2022 to 10/28/2026

Comprehensive metric breakdowns and analytics for Align Technology, Inc. (ALGN)

- price and consensus price forecast:
Market Chart Invisalign|ALGN - Price Target Chart
- market capitalization data:
Market Valuation Align Technology, Inc.|ALGN - Enterprise Value
- book capitalization data:
Net Asset Value per Share Align Technology|ALGN - Book Capitalization|Market Cap to Net Assets Ratio aligntech.com|ALGN - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient Align Technology, Inc.|ALGN - Long-Term Debt to Capital|Short-Term Debt to Capital aligntech.com|ALGN - Company Debts|Debt to Book Capitalization Ratio Align Technology, Inc.|ALGN - Company Long-Term Debts|Short-Term Debt Volume Align Technology
Comprehensive company analysis:ALGN, Invisalign
Core merchandise of Align Technology, Inc.

Global diversification of Invisalign aligner and iTero scanner sales minimizes Align Technology, Inc. (ALGN) dependence on local crises, creating a foundation for the stable funding of obligations. An analysis of the long-term debt-to-equity ratio allows for an assessment of the business's default resilience by comparing long-term loans with equity, where an upward trend on the chart signals rising financial risks.

Direct competitors

Ratio of Long-Term Indebtedness to Capital BSX|EW - Long-Term Debt to Equity|Long-Term Liabilities to Equity ResMed Corporation (RMD)|PODD: Long-Term Debt to Capital|Long-Term Liabilities to Capital Zimmer ZBH|COO: Long-Term Debt to Capital|GMED - Long-Term Debt to Equity Ratio|TransMedics - Long-Term Debt to Capital|Alphatec Corp (ATEC) - Ratio of Long-Term Indebtedness to Capital|AORT (Artivion, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital ENOV|Long-Term Debt to Equity Integra LifeSciences Holdings Corporation (IART)|Long-Term Debt to Equity Establishment Labs Corp (ESTA)|Long-Term Debt to Capital BBNX|IRMD - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Ratio Embecta Corp.|TNDM - Long-Term Liabilities to Equity|Long-Term Debt to Capital AXGN|SI-BONE Inc (SIBN) - Long-Term Liabilities to Capital|Long-Term Debt to Capital Orthofix International (OFIX)|Long-Term Debt to Capital Ratio Bioventus Global (BVS)|OrthoPediatrics Corp. (KIDS) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient TMCI (treace.com)|Strata Critical Medical - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Carlsmed, Inc. CARL|RXST (RxSight Corp) - Long-Term Debt to Capital|CLPT - Long-Term Liabilities to Capital|Long-Term Debt to Capital Stereotaxis, Inc.|neurostar.com (STIM) - Long-Term Debt to Capital Ratio|SGHT: Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Orchestra BioMed Inc.|Long-Term Debt to Capital ANIK (Anika Therapeutics)|Long-Term Debt to Equity Ratio InspireMD Inc. (NSPR)|Long-Term Debt to Capital ZJYL (Jin Medical)|Vivani Medical Inc - Long-Term Debt to Capital|XTNT - Long-Term Debt to Equity|NeuroOne (NMTC) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio modular-medical.com MODD|Myomo Inc (MYO) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital COCH (Envoy Medical, Inc.)|Long-Term Liabilities to Capital VVOS|NVNO: Long-Term Debt to Equity|Long-Term Indebtedness to Equity sintx.com SINT|Long-Term Debt to Equity Ratio TNON (Tenon Medical, Inc)|Long-Term Debt to Capital Lifeward Ltd. LFWD|Long-Term Debt to Capital AMIX (Autonomix)|IVF: Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Bone Biologics Corp (BBLG)|AXNX (Axonics Inc.) - Long-Term Liabilities to Equity|Long-Term Debt to Equity BIOL|Long-Term Debt to Equity Ratio Dynatronics Corp.|Paragon 28, Inc. - Long-Term Debt to Capital|Long-Term Liabilities to Capital INVO (invobioscience.com)